A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus
Clinical trial NCT05856448 · COMPLETED
Trial details
- NCT number
- NCT05856448
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2025-10-08
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.